The biosensors market size was USD 24.60 billion in 2022 & it will surpass USD 54.21 billion by 2030, following a CAGR of 9.30% in the forecast by 2030.

The automation testing market worth which was USD 24.23 billion in 2022, crosses USD 85.44 billion by 2030, following a CAGR of 17.06% by the forecast period.

The Biomaterials Market was valued at USD 176.73 Billion in 2023 and is projected to reach up to USD 503.42 Billion, with a CAGR of 13.98% by 2031.

Global Companion Diagnostics Market, By Product and Services (Assay Kits and Reagents, Software & Services), Technology (Polymerase Chain Reaction, Molecular Diagnostics, FISH, CISH, Immunohistochemistry, Real-time PCR,  Next-Generation Sequencing, Gene Sequencing, In Situ Hybridization), Indication (Oncology, Neurology, Infectious Diseases), Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, Urology, Gastric Cancer), End Users (Pharmaceutical and Biopharmaceutical Companies, Reference Laboratories), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

The blockchain market value rises following a CAGR of 71.96% surpassing USD 766.10 billion in the forecast period by 2030 from USD 10.02 billion in 2022.